Eagle Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eagle Pharmaceuticals

08/08/2023 14:34

* Eagle Pharmaceuticals Inc  EGRX.OQ  reported quarterly
adjusted
earnings of $1.18​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was
for earnings of $1.05 per share.
    * Revenue fell 12.8% to $64.65 million from a year ago;
analysts
expected $59.36 million. 
    * Eagle Pharmaceuticals Inc's reported EPS for the quarter
was 39
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Eagle Pharmaceuticals Inc shares had risen by 12.2% this
quarter and lost 25.4% so far this year.
    * The company reported quarterly net income of $5.16
million.
    * Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 01:34 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      1.05           1.18           Beat
 Mar. 31 2023      1.05           1.26           Beat
 Dec. 31 2022      0.83           1.10           Beat
 Sep. 30 2022      0.91           1.12           Beat